Overview
Dentinogenesis imperfecta type 2 (DGI-II), also known as hereditary opalescent dentin, is a genetic disorder affecting the dentin — the hard tissue that forms the bulk of the tooth beneath the enamel. It is the most common hereditary disorder of dentin and is caused by mutations in the DSPP (dentin sialophosphoprotein) gene located on chromosome 4q22.1. DGI-II affects both the primary (baby) and permanent teeth, though primary teeth are typically more severely affected. Clinically, teeth affected by DGI-II have a characteristic translucent or opalescent appearance, ranging in color from amber to blue-gray or brownish. The enamel, although structurally normal, tends to chip away easily from the abnormal underlying dentin, exposing the softer dentin to rapid wear and attrition. The dentin itself is poorly mineralized and disorganized, and the pulp chambers of the teeth are often obliterated (sclerosed) over time. Patients may experience significant tooth wear, fractures, and early tooth loss. Unlike dentinogenesis imperfecta type 1, DGI-II occurs as an isolated dental condition without associated bone fragility or osteogenesis imperfecta. There is currently no cure for DGI-II. Treatment is focused on preserving tooth structure, preventing excessive wear, and maintaining dental function and aesthetics. Management strategies include the use of stainless steel crowns or full-coverage restorations in children to protect primary teeth, composite or porcelain restorations for permanent teeth, and in severe cases, overdentures or dental implants in adulthood. Early dental intervention and regular follow-up with a pediatric dentist or prosthodontist are essential to optimize outcomes and quality of life.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Dentinogenesis imperfecta type 2.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Dentinogenesis imperfecta type 2 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Dentinogenesis imperfecta type 2.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Dentinogenesis imperfecta type 2.
Community
No community posts yet. Be the first to share your experience with Dentinogenesis imperfecta type 2.
Start the conversation →Latest news about Dentinogenesis imperfecta type 2
No recent news articles for Dentinogenesis imperfecta type 2.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Dentinogenesis imperfecta type 2
What is Dentinogenesis imperfecta type 2?
Dentinogenesis imperfecta type 2 (DGI-II), also known as hereditary opalescent dentin, is a genetic disorder affecting the dentin — the hard tissue that forms the bulk of the tooth beneath the enamel. It is the most common hereditary disorder of dentin and is caused by mutations in the DSPP (dentin sialophosphoprotein) gene located on chromosome 4q22.1. DGI-II affects both the primary (baby) and permanent teeth, though primary teeth are typically more severely affected. Clinically, teeth affected by DGI-II have a characteristic translucent or opalescent appearance, ranging in color from amber
How is Dentinogenesis imperfecta type 2 inherited?
Dentinogenesis imperfecta type 2 follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Dentinogenesis imperfecta type 2 typically begin?
Typical onset of Dentinogenesis imperfecta type 2 is childhood. Age of onset can vary across affected individuals.